We’ll help you find the highest quality medicine that you need.
Nexavar
is indicated for the treatment of patients with advanced renal cell carcinoma.
Manufactured by: Bayer Healthcare
Active Ingredient(s): Sorafenib Tosylate
Dosage Form: Film coated tablets, oral
Strength: Each tablet contains Sorafenib Tosylate (274 mg) equivalent to 200 mg of Sorafenib
FDA approved: December 1, 2005
More information about Nexavar:
https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/021923s015lbl.pdf